OneMedNet Announces Board Member Transition to Drive Growth Post-IPO MINNEAPOLIS, OCTOBER 2 , 2024 (GLOBE NEWSWIRE) - OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory

Announces Board Member Transition

to Drive Growth Post-IPO

2024 (GLOBE NEWSWIRE) -

OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade

Real World Data (RWD), is pleased to announce

a strategic refresh of its Board of Directors following the successful transition to a publicly traded entity. This move reinforces our

commitment to dynamic leadership and active engagement as we accelerate growth in this new phase.

extend our heartfelt gratitude to Paul Casey, and Erkan Akyuz for their invaluable contributions during a pivotal time

in our company's history. Their leadership and guidance were instrumental in achieving our IPO, laying a strong foundation as OneMedNet

entered the public markets. We thank them for their service and wish them the best in their future endeavors.

alignment with our vision for the future, we are excited to welcome two distinguished individuals to our Board.

Clarke, currently serves as Executive Advisor to the Chairman at World Wide Technology (WWT), holds the position of CEO at Laigic

member of Xponential NYSE:XPOF) that is focused on health and wellness. His career also includes a tenure as a Global CTO at Microsoft,

where he was pivotal in shaping the company's technological direction. Prior to this, he led Disney's Big Data, technology

strategy and digital intelligence and co-led IBM Watson's strategy and delivery.

experience positions him to contribute to the following business priorities:

Coonse McCraw, currently the VP of Human Resources and former CFO of BMW North America, brings a diverse background in both finance

and human capital strategy. As the new head of our audit committee, her expertise will be critical in:

is at an exciting juncture, and the addition of Sherry and Jair to our Board is a testament to our commitment to excellence and innovation,"

said Jeffrey Yu, MD, Founder and Chairman of OneMedNet. "We are grateful for the foundational work of Paul and Erkan, and

with Sherry and Jair onboard, we are well-positioned to drive our company towards new heights."

transition reflects our strategic focus on enhancing corporate governance, leveraging diverse expertise, and ensuring that our Board

is equipped to guide OneMedNet through its next phase of growth and innovation.

OneMedNet Corporation

provides innovative solutions that unlock the significant value contained within the Real-World Data ("RWD") repositories

of over 1,400 healthcare system and provider sites that currently comprise its iRWD network. OneMedNet's proprietary iRWD

platform provides secure, comprehensive management of diverse clinical data types, including electronic health records, laboratory results,

and uniquely, medical imaging. Employing its robust iRWD platform, the Company securely de-identifies, searches, and curates the

clinical data, bringing a wealth of internal and third-party research opportunities to its drug, medical device and imaging/diagnostic

AI development customers.

platform is designed to meet the clinical requirements necessary across various domains, including but not limited to rare diseases,

oncology, and cardiology. The Company is

committed to delivering precise and robust research support services that span the entire continuum of care. This commitment is a cornerstone

of OneMedNet's strategy to enhance patient outcomes and help pave the next wave of healthcare innovation. For more information,

please visit www.onemednet.com.

Note Regarding Forward-Looking Statements

press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking

statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which

we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance,

including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities.

You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such

as "may," "should," "expects," "anticipates," "contemplates," "estimates,"

"believes," "plans," "projected," "predicts," "potential," or "hopes"

or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including:

our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; and the competitive

environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.

Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made

from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to

risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether

as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from

time to time by us or our representatives might not occur.

Wong, Director of Marketing

ONEMEDNET CORPORATION